Improved survival after laparoscopic compared to open gastrectomy for advanced gastric cancer: a Swedish population-based cohort study

Background

Laparoscopic gastrectomy is increasingly used for the treatment of locally advanced gastric cancer but concerns remain whether similar results can be obtained compared to open gastrectomy, especially in Western populations. This study compared the short-term postoperative, oncological and survival outcomes following laparoscopic versus open gastrectomy based on data from the Swedish National Register for Esophageal and Gastric Cancer.

Methods

Patients who underwent surgery with curative intent for adenocarcinoma of the stomach or gastroesophageal junction Siewert type III from 2015 to 2020 were identified, and 622 patients with cT2-4aN0-3M0 tumors were included. The impact of surgical approach on short-term outcomes was assessed using multivariable logistic regression. Long-term survival was compared using multivariable Cox regression.

Results

In total, 350 patients underwent open and 272 laparoscopic gastrectomy, of which 12.9% were converted to open surgery. The groups were similar regarding distribution of clinical disease stage (27.6% stage I, 46.0% stage II, and 26.4% stage III). Neoadjuvant chemotherapy was administered to 52.7% of the patients. There was no difference in the rate of postoperative complications, but laparoscopic approach was associated with lower 90 day mortality (1.8 vs 4.9%, p = 0.043). The median number of resected lymph nodes was higher after laparoscopic surgery (32 vs 26, p < 0.001), while no difference was found in the rate of tumor-free resection margins. Better overall survival was observed after laparoscopic gastrectomy (HR 0.63, p < 0.001).

Conclusions

Laparoscopic gastrectomy can be safely preformed for advanced gastric cancer and is associated with improved overall survival compared to open surgery.

     

Lead levels in Canadian children: Do we have to review the standard?

Research indicates that the blood lead levels that were once considered safe can adversely affect the neurodevelopment of children. The purpose of the present article is to review issues surrounding lead exposure in Canadian children, including sources, chronic low levels of exposure, and recommendations for prevention. Information was obtained through searches of MEDLINE and Web of Science using a combination of: “Canada” or “Canadian” plus “child” or “paediatrics” plus “lead” or “lead poisoning” or “blood lead”. Centers for Disease Control and Prevention data and American peer-reviewed literature were also used. On-line Health Canada advisories (available since 1995), as well as relevant reports from nongovernmental organization and the media, were reviewed. The present review found that there has been limited surveillance of blood lead levels of Canadian children and, mainly, among high-risk groups. Harmful health effects may occur below the current standards and the threat of lead in consumer products remains. The current regulation seems to be inadequate to protect Canadian children.